These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21847537)

  • 21. Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder.
    Grandjean EM; Aubry JM
    CNS Drugs; 2009; 23(3):225-40. PubMed ID: 19320531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bipolar disorder.
    Belmaker RH
    N Engl J Med; 2004 Jul; 351(5):476-86. PubMed ID: 15282355
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients.
    Tondo L; Baldessarini RJ
    Epidemiol Psichiatr Soc; 2009; 18(3):179-83. PubMed ID: 20034193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using Lithium in Older Age Bipolar Disorder: Special Considerations.
    Fotso Soh J; Klil-Drori S; Rej S
    Drugs Aging; 2019 Feb; 36(2):147-154. PubMed ID: 30613911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study.
    Kessing LV; Hellmund G; Geddes JR; Goodwin GM; Andersen PK
    Br J Psychiatry; 2011 Jul; 199(1):57-63. PubMed ID: 21593515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacological treatment of bipolar disorder: the question of modern advances.
    Hirschowitz J; Kolevzon A; Garakani A
    Harv Rev Psychiatry; 2010; 18(5):266-78. PubMed ID: 20825264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lithium paradox: declining prescription of the gold standard treatment for bipolar disorder.
    Bartoli F
    Acta Psychiatr Scand; 2023 Mar; 147(3):314-315. PubMed ID: 36527204
    [No Abstract]   [Full Text] [Related]  

  • 28. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.
    Stedman M; Pettinati HM; Brown ES; Kotz M; Calabrese JR; Raines S
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1822-31. PubMed ID: 20626727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter study.
    Morlet E; Costemale-Lacoste JF; Poulet E; McMahon K; Hoertel N; Limosin F;
    J Affect Disord; 2019 Dec; 259():210-217. PubMed ID: 31446382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic evidence for manic episode].
    Terao T
    Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment-refractory bipolar disorder: classification to aid in clinical management.
    Gajwani P
    Expert Opin Pharmacother; 2009 Aug; 10(12):1907-15. PubMed ID: 19606936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing the Malignant Transformation of Bipolar Disorder.
    Post RM
    JAMA; 2018 Mar; 319(12):1197-1198. PubMed ID: 29507950
    [No Abstract]   [Full Text] [Related]  

  • 33. [The relationship between intake of lithium and neuroradiological alterations in bipolar disorder. Are there predictors of clinical remission?].
    Hamm C; Queissner R; Pilz R; Birner A; Platzer M; Fellendorf F; Maget A; Bengesser S; Dalkner N; Reininghaus B; Reininghaus E
    Fortschr Neurol Psychiatr; 2019 Sep; 87(9):483-491. PubMed ID: 30453335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
    Ventriglio A; Vincenti A; Centorrino F; Talamo A; Fitzmaurice G; Baldessarini RJ
    Int Clin Psychopharmacol; 2011 Mar; 26(2):88-95. PubMed ID: 21030870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bipolar disorder and the risk of fracture: A nationwide population-based cohort study.
    Su JA; Cheng BH; Huang YC; Lee CP; Yang YH; Lu ML; Hsu CY; Lee Y; McIntyre RS; Chin Lin T; Chin-Hung Chen V
    J Affect Disord; 2017 Aug; 218():246-252. PubMed ID: 28477503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lithium: clinical considerations in internal medicine.
    Freeman MP; Freeman SA
    Am J Med; 2006 Jun; 119(6):478-81. PubMed ID: 16750958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polypharmacy and suicide attempts in bipolar disorder.
    Gazalle FK; Hallal PC; Tramontina J; Rosa AR; Andreazza AC; Zanatto V; Santin A; Kapczinski F; Ceresér KM
    Braz J Psychiatry; 2007 Mar; 29(1):35-8. PubMed ID: 17435926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania.
    Yatham LN; Binder C; Kusumakar V; Riccardelli R
    Int Clin Psychopharmacol; 2004 Mar; 19(2):103-9. PubMed ID: 15076019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations.
    Malhi GS; Tanious M
    CNS Drugs; 2011 Apr; 25(4):289-98. PubMed ID: 21425882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium and cognition in those with bipolar disorder.
    Paterson A; Parker G
    Int Clin Psychopharmacol; 2017 Mar; 32(2):57-62. PubMed ID: 27741027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.